Morgan Stanley vs T-Rex 2X Inverse MSTR Daily Target ETF — how do they compare? Morgan Stanley trades at $188.9 (market cap $294.39B), while T-Rex 2X Inverse MSTR Daily Target ETF trades at $2.6 (market cap $94.46M). The key difference: Morgan Stanley is far larger — about 3116.6× T-Rex 2X Inverse MSTR Daily Target ETF's market cap, and Morgan Stanley pays a 2.45% dividend while T-Rex 2X Inverse MSTR Daily Target ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold Morgan Stanley for 93 Days and T-Rex 2X Inverse MSTR Daily Target ETF for 8 Days on average.
| MS | MSTZ | |
|---|---|---|
Market Cap | $294.39B | $94.46M |
Volume | 5,836,423 | 104,717,733 |
Sector | Financials | Leveraged / Inverse |
52-Week High | $228.42 | $27.92 |
52-Week Low | $151.86 | $2.29 |
Typical Hold Time | 93 Days | 8 Days |
Enterprise Value | $660.04B | — |
Dividend Yield | 2.45% | — |
Signals from Pluang's Aura AI — not financial advice
Morgan Stanley (MS) trades at $189.71, down 0.66% with bearish technical signals despite strong fundamentals. The company has delivered three consecutive earnings beats with Q2 2026 EPS of $3.46 beating expectations by $0.57. Revenue growth accelerated to $66.0 billion in 2025 with net income margin expanding to 27.59%. Analyst consensus remains bullish with 55.77% buy ratings and a $229.25 price target representing 21% upside potential.
The investment case balances strong profitability and growth opportunities in wealth management and AI financing against concerning cash flow trends and technical weakness. While valuation appears reasonable at 15.14 P/E, investors face risks from volatile operating cash flows and rising debt levels. The stock offers attractive upside to analyst targets but requires monitoring of capital markets recovery timing.
MSTZ is trading at $2.54, down 4.51% today, with technical indicators showing a bearish trend as moving averages signal selling pressure. The stock lacks key financial ratio data, making fundamental assessment challenging. Recent ETF coverage highlights its inclusion in leveraged/inverse ETF discussions, though specific company performance details are limited.
The outlook remains cautious due to incomplete financial disclosures and bearish technical signals. Investment opportunities depend on forthcoming earnings clarity, while risks include volatility from limited institutional coverage and market sentiment shifts. Investors should await detailed financial updates for informed decisions.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Morgan Stanley is a global investment bank whose history, through its legacy firms, can be traced back to 1924. The company has institutional securities, wealth management, and investment management segments. The company had about $5 trillion of client assets as well as over 70,000 employees at the end of 2021. Approximately 50% of the company's net revenue is from its institutional securities business, with the remainder coming from wealth and investment management. The company derives about 30% of its total revenue outside the Americas.
Read more on MS →MSTZ is a leveraged ETF that seeks daily investment results corresponding to 200% of the inverse (opposite) of the daily performance of the MicroStrategy Incorporated (MSTR) stock. It is designed as a tactical tool for experienced traders to take a bearish position on MSTR, a company known for its large Bitcoin holdings. Due to the effects of compounding and leverage, the ETF is intended to be held for a single day and is not suitable for long-term investment, as its performance over longer periods may significantly deviate from its stated daily objective.
Read more on MSTZ →